CA1030522A - D-homo-20-keto-pregnanes - Google Patents

D-homo-20-keto-pregnanes

Info

Publication number
CA1030522A
CA1030522A CA215,097A CA215097A CA1030522A CA 1030522 A CA1030522 A CA 1030522A CA 215097 A CA215097 A CA 215097A CA 1030522 A CA1030522 A CA 1030522A
Authority
CA
Canada
Prior art keywords
pregnanes
keto
homo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA215,097A
Other languages
English (en)
French (fr)
Other versions
CA215097S (en
Inventor
Klaus Kieslich
Karl Petzoldt
Rudolf Wiechert
Reinhard Horowski
Gert Paschelke
Dieter Palenschat
Ulrich Kerb
Helmut Wachtel
Wolfgang Kehr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of CA1030522A publication Critical patent/CA1030522A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
CA215,097A 1973-11-30 1974-12-02 D-homo-20-keto-pregnanes Expired CA1030522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
CA1030522A true CA1030522A (en) 1978-05-02

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
CA215,097A Expired CA1030522A (en) 1973-11-30 1974-12-02 D-homo-20-keto-pregnanes

Country Status (14)

Country Link
US (1) US4045574A (en:Method)
JP (1) JPS5084561A (en:Method)
AT (1) AT347611B (en:Method)
CA (1) CA1030522A (en:Method)
CH (1) CH618183A5 (en:Method)
DD (1) DD115659A5 (en:Method)
DK (1) DK134348C (en:Method)
ES (1) ES432106A1 (en:Method)
FR (1) FR2253512B1 (en:Method)
GB (1) GB1494097A (en:Method)
IE (1) IE40423B1 (en:Method)
IL (1) IL46153A (en:Method)
NL (1) NL7415577A (en:Method)
SE (1) SE408426B (en:Method)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
ES2271636T3 (es) * 2002-08-16 2007-04-16 PHARMACIA & UPJOHN COMPANY LLC Intermediarios de 5 androsten-3-ol esteroides y procedimientos para su preparacion.
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
MX395023B (es) 2013-04-17 2025-03-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3-disustituidos y metodos de uso de los mismos.
PT2986624T (pt) 2013-04-17 2020-07-07 Sage Therapeutics Inc Esteroides neuroativos 19-nor para métodos de tratamento
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
RU2754534C2 (ru) 2013-07-19 2021-09-03 Сейдж Терапьютикс, Инк. Нейроактивные стероиды, композиции и их использование
BR112016003862B1 (pt) 2013-08-23 2022-09-06 Sage Therapeutics, Inc Compostos esteroides neuroativos, suas composições e seus usos
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
CN107404877A (zh) 2014-10-16 2017-11-28 萨奇治疗股份有限公司 靶向cns 障碍的组合物和方法
HRP20200840T1 (hr) 2014-11-27 2020-11-13 Sage Therapeutics, Inc. Pripravci i postupci za liječenje poremećaja cns-a
HUE054092T2 (hu) 2015-01-26 2021-08-30 Sage Therapeutics Inc Központi idegrendszeri zavarok kezelésére szolgáló kompozíciók és eljárások
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CA3030420A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
EP4302764A3 (en) 2016-07-11 2024-06-26 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
CN118772223A (zh) * 2017-12-22 2024-10-15 萨奇治疗股份有限公司 治疗中枢神经系统疾病的组合物和方法
CA3120872A1 (en) 2018-12-05 2020-06-11 Sage Therapeutics, Inc. Neuroactive steroids and their methods of use
JOP20210293A1 (ar) 2019-05-31 2023-01-30 Sage Therapeutics Inc ستيرويدات ذات فعالية عصبية وتركيبات منها
CA3144701A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
AU2020304679A1 (en) * 2019-06-27 2022-01-20 Sage Therapeutics, Inc. Compounds for treating CNS disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
ATA950774A (de) 1978-05-15
NL7415577A (nl) 1975-06-03
DD115659A5 (en:Method) 1975-10-12
GB1494097A (en) 1977-12-07
DK604174A (en:Method) 1975-07-28
IL46153A0 (en) 1975-02-10
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
AT347611B (de) 1979-01-10
DK134348C (da) 1977-03-21
IL46153A (en) 1979-01-31
JPS5084561A (en:Method) 1975-07-08
FR2253512B1 (en:Method) 1978-02-03
SE408426B (sv) 1979-06-11
DK134348B (da) 1976-10-25
AU7586774A (en) 1976-06-03
FR2253512A1 (en:Method) 1975-07-04
US4045574A (en) 1977-08-30
CH618183A5 (en:Method) 1980-07-15
SE7414960L (en:Method) 1975-06-02
IE40423B1 (en) 1979-05-23

Similar Documents

Publication Publication Date Title
AU474137B2 (en) Auto-refractometer
AU468964B2 (en) Melik
CA1034948A (en) Triazolopyridazines
CA1005601A (en) Pack-bed
AU498889B2 (en) Piperidylene benzocycloheptathiophenes
AU476397B2 (en) A-cycloalkylbenzyl lactamimides
CA1031258A (en) Para-influenza-3-virus
AU476505B2 (en) Alkylbenxyl lactamimides
AU472907B2 (en) Firecheck
CA971440A (en) Headgate
CA1032172A (en) Fluoroaliphaticthiomethylsilanes
CA1015606A (en) Tyreroller
AU476386B2 (en) Dibenzocycloheptenyl lactamimides
CA1018166A (en) Benzylpyrimidines
AU471241B2 (en) Benzothiazolylureas
CA1019735A (en) Thienodiazepines
AU478880B2 (en) 3-isoxazolidinones
AU479426B2 (en) Carbothiolates
AU466103B2 (en) Cis-chrysanthemate
AU492033B2 (en) D-homo-20-keto-pregnanes
AU489559B2 (en) Amidinoureas
AU492247B2 (en) Ethenoanthracenes
AU489560B2 (en) Amidinoureas
AU492165B2 (en) 2-hydroxyphenyl-1-oxa-4 azaspiro-alkan-derivatives
AU491458B2 (en) 7-halomethyl-17-hydroxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones